Skip to content
Review

Abstract A017: Substance use disorder prevalence among cancer survivors in the United States: A nationally representative analysis

Oct 2026 · Cancer Epidemiology, Biomarkers & Prevention · Vol 35, pp. A017-A017 · 0 citations

TL;DR

The findings highlight the need for cancer-type-specific SUD screening and underscore the importance of examining psychosocial and treatment-related pathways driving substance use disparities in this population.

Abstract

Cancer survivors represent a growing and medically complex population in the U.S. Substance use disorders (SUDs) are an underrecognized comorbidity in this population, yet population-level data on SUD prevalence across cancer types remain limited. This study estimated the weighted prevalence of SUDs across 17 cancer types among U.S. cancer survivors and examined cancer type as a predictor of any SUD among women. This is a cross-sectional analysis of data from the combined 2021–2024 National Survey on Drug Use and Health (NSDUH) Public Use File. The analytic sample included adults aged 18 years and older with a self-reported lifetime cancer diagnosis. SUD outcomes were defined using DSM-5 recoded variables and included past-year any SUD, alcohol, cannabis, opioid, stimulant, sedative, and other SUDs. Weighted proportions of sociodemographic characteristics and SUD prevalence estimates were calculated using NSDUH-specified survey design parameters. Among women, a survey-weighted logistic regression examined the association between cancer type and any SUD. The analytic sample included 7612 adult cancer survivors (56.49% were female and 57.64% were aged 65 years or older). Overall, 9.91% (95% CI: 8.64, 11.18) of cancer survivors met criteria for any past-year SUD. Alcohol use disorder was the most prevalent disorder (7.40%; 95% CI: 6.19, 8.60), followed by cannabis use disorder (2.30%; 95% CI: 1.84, 2.76). Opioid, stimulant, sedative, and other SUDs were each present in less than 1% of cancer survivors overall. Substantial variation in SUD prevalence was observed across cancer types. The highest prevalence of any SUD was observed among survivors of cervical cancer (19.02%), other cancer types (15.28%), and thyroid cancer (13.14%). In contrast, ovarian cancer survivors had the lowest prevalence of any SUD (2.60%; 95% CI: 0.09, 5.11). Alcohol use disorder was the predominant SUD across nearly all cancer types, with notably high estimates observed among cervical (11.16%), thyroid (10.75%), and bladder (10.09%) cancer survivors. Cervical cancer survivors had the highest prevalence of opioid (3.99%) and stimulant (2.49%) SUDs compared to other cancer types. In the logistic regression among women, after controlling for age, race/ethnicity, marital status, education, family income, insurance status, and survey year, a history of ovarian cancer was significantly associated with lower odds of any past-year SUD compared to women with no cancer history (aOR: 0.25; 95% CI: 0.09, 0.68). Women with a history of cervical cancer demonstrated higher odds of any past-year SUD (aOR: 1.75; 95% CI: 1.01, 3.02). In this nationally representative analysis, approximately 1 in 10 U.S. cancer survivors met criteria for a past-year SUD, with marked variation by cancer type. These findings highlight the need for cancer-type-specific SUD screening and underscore the importance of examining psychosocial and treatment-related pathways driving substance use disparities in this population. Sarah O'Shea, Ana Tergas. Substance use disorder prevalence among cancer survivors in the United States: A nationally representative analysis [abstract]. In: Proceedings of the 19th AACR Conference on the Science of Cancer Health Disparities; 2026 Oct 18-21; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2026;35(10 Suppl):Abstract nr A017.

View source

Similar papers

Open access Oct 2026

Sex differences in depression and substance use disorder diagnoses and overdose risk in British Columbia

Background: Depression is a risk factor for overdose and is more commonly diagnosed among females. However, sex-differences in the association between depression, in isolation and in combination with substance use disorder (SUD), and overdose have not been examined at the population level in British Columbia (BC). This...

H. Palis, J. Vincent · 0 citations
Oct 2026

Abstract A024: Substance use disorder–associated cancer mortality in the United States, 1999–2020: Widening geographic and rural–urban disparities

Substance use disorders (SUDs) and cancer share behavioral, commercial, environmental, and structural drivers, including tobacco, alcohol, drug exposure, psychosocial stress, deprivation, and unequal access to prevention, diagnosis, harm reduction, and oncology care. National mortality patterns for cancer deaths...

Lakshmi Chandana Velaga, F. Bhuvan, Prithvi Raghavan et al. · 0 citations
Review Open access Oct 2026

Substance use profiles predict health outcomes among U.S. adults with diabetes: Implications for primary care screening and intervention.

AIMS Substance use is common among adults with diabetes yet remains poorly characterized in terms of co-occurring patterns. This study sought to identify distinct substance use profiles among U.S. adults with diabetes, characterize factors associated with profile membership, and examine their clinical relevance. METH...

Thomas E. Burroughs, Jun-Hong Chen, B. Varghese et al. · 0 citations
Open access Oct 2026

Demographic, Social, and Behavioral Predictors of Substance Use During Medication-Assisted Treatment

Opioid Use Disorder (OUD) remains a critical public health issue in the United States. While Medications for Opioid Use Disorder (MOUD) are an effective and growing treatment option for OUD, use and integration into care remains low. This paper examines the effect of understudied demographic, social, and beh...

Jack Samuel Womack, Manik Ahuja, Praveen Fernandopulle · 0 citations
Review Open access Oct 2026

Time to generalized anxiety disorder onset after substance use disorder: a survival analysis from a national sample.

Across SUD groups, younger age, comorbid non-GAD anxiety, mood, and personality disorders were consistently associated with increased risk, whereas remission was protective, and these results may inform targeted screening, monitoring, and prevention strategies to interrupt development of GAD.

Xiao-Xi Zhang, B. Le Foll, A. Hassan · 0 citations
Review Open access Nov 2026

Prevalence and Correlates of Substance Use Among Sexual and Gender Minority Youth and Young Adults in North Carolina

High substance use prevalence among SGM youth and young adults in NC is identified and several factors were associated with substance use, including race/ethnicity, gender identity, perceived harms, future orientation, perceived parental and peer use, and perceived discrimination.

L. Mann-Jackson, Thomas P. McCoy, P. J. Ballard et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.